News
RDTCF
0.079
NaN%
--
Rapid Dose Therapeutics Secures Indian Patent for QuickStrip Nicotine Bilayer Oral Film
Reuters · 03/05 15:08
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
Newsfile · 03/05 15:08
Rapid Dose Wins Key Indian Patent for QuickStrip Nicotine Oral Film
TipRanks · 03/05 14:21
Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
TipRanks · 02/23 14:43
Rapid Dose Therapeutics Updates QuickStrip Cannabinoid Research and CBD Bioavailability Study Progress
Reuters · 02/23 14:19
Rapid Dose Therapeutics advances CBD QuickStrip clinical bioavailability study
Reuters · 02/23 11:13
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
Newsfile · 02/23 11:12
Rapid Dose Therapeutics Begins Trading on OTCQB in US
Reuters · 02/12 08:03
Rapid Dose Therapeutics Lists on U.S. OTCQB to Broaden Investor Access
TipRanks · 02/11 17:09
Rapid Dose Therapeutics Shares Begin Trading on U.S. OTCQB Market
Reuters · 02/11 16:23
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors
Newsfile · 02/11 16:21
Rapid Dose Therapeutics Launches QuickStrip Medical Cannabis in Brazil
Reuters · 02/11 08:29
Rapid Dose Therapeutics Enters Brazil’s Medical Cannabis Market With QuickStrip Launch
TipRanks · 02/10 13:36
Rapid Dose Therapeutics Receives ANVISA Approval for QuickStrip Medical Cannabis in Brazil
Reuters · 02/10 12:04
Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment
Newsfile · 02/10 12:00
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Newsfile · 01/05 22:30
Rapid Dose Completes Extension to Promissory Notes
Newsfile · 12/09/2025 00:19
Rapid Dose Announces Extension to Promissory Notes
Newsfile · 11/29/2025 01:14
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner
Newsfile · 10/20/2025 12:48
Weekly Report: what happened at RDTCF last week (0908-0912)?
Weekly Report · 09/15/2025 10:32
More
Webull provides a variety of real-time RDTCF stock news. You can receive the latest news about Rapid Dose Thera through multiple platforms. This information may help you make smarter investment decisions.
About RDTCF
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.